Price movement over the last 24 hours
AbCellera Biologics Inc vs Nutrien Ltd — how do they compare? AbCellera Biologics Inc trades at $7.1 (market cap $2.35B), while Nutrien Ltd trades at $66.83 (market cap $31.34B). The key difference: Nutrien Ltd is far larger — about 13.3× AbCellera Biologics Inc's market cap, and Nutrien Ltd pays a 3.37% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | NTR | |
|---|---|---|
Market Cap | $2.35B | $31.34B |
Sector | Health | Basic Materials |
52-Week High | $8.12 | $83.94 |
52-Week Low | $2.78 | $53.64 |
Enterprise Value | $1.99B | $44.51B |
Dividend Yield | — | 3.37% |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →